Home > Offer to Sell > Pharmaceuticals and Biochemicals > Auxiliaries and miscellaneous medicinal chemicals > Tofacitinib citrate
Tofacitinib citrate
Inquiry
Post Date: | Sep 28,2013 |
Expiry Date: | Sep 28,2014 |
Detailed Description: |
Cas No. :540737-29-9
Specs:Tablet, 5 mg This product is the treatment of rheumatoid arthritis drugs. |
CAS Registry Number: | 540737-29-9 |
Synonyms: | ;Tofacitinib citrate;1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Ylamino)-Beta-Oxo-, (3R,4R)-, 2-Hydroxy-1,2,3-Propanetricarboxylate (1:1);1-PIPERIDINEPROPANENITRILE,4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-,(3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE(1:1);Tasocitinib citrate;(3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate;Tofacitnib Citrate; |
Molecular Formula: | C16H20N6O·C6H8O7 |
Molecular Weight: | 504.497 |
Molecular Structure: |
Company: | RennoTech Co., Ltd. |
Contact: | March |
Tel: | 025-58353800 |
Fax: | 025-58353700 |
Email: | sales@rennotech.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.